share_log
Breakings ·  Nov 8 05:05

Nov 07 (Reuters) - Athira Pharma Q3 Operating Expenses USD 29.621 Million.

  • Q3 Net Income USD -28.741 Million
  • Q3 Operating Income USD -29.621 Million
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment